My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 280

    1.

    Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes.

    Braghi S, Bonifacio E, Secchi A, Di Carlo V, Pozza G, Bosi E.

    Diabetes. 2000 Feb;49(2):218-24.PMID: 10868938 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation.

    Thivolet C, Abou-Amara S, Martin X, Lefrancois N, Petruzzo P, McGregor B, Bosshard S, Dubernard JM.

    Transplantation. 2000 Jan 15;69(1):99-103.PMID: 10653387 [PubMed - indexed for MEDLINE]Related articles

    3.

    International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.

    Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B.

    Diabetes. 2001 Nov;50(11):2451-8. Review.PMID: 11679421 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.

    Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA.

    Diabetologia. 1998 Aug;41(8):891-7.PMID: 9726590 [PubMed - indexed for MEDLINE]Related articles

    5.

    Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.

    Roll U, Christie MR, Füchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG.

    Diabetes. 1996 Jul;45(7):967-73.PMID: 8666150 [PubMed - indexed for MEDLINE]Related articles

    6.

    Autoantibody response to islet transplantation in type 1 diabetes.

    Bosi E, Braghi S, Maffi P, Scirpoli M, Bertuzzi F, Pozza G, Secchi A, Bonifacio E.

    Diabetes. 2001 Nov;50(11):2464-71.PMID: 11679423 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

    Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

    Metabolism. 2003 Jan;52(1):25-9.PMID: 12524658 [PubMed - indexed for MEDLINE]Related articles

    8.

    Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.

    Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE.

    J Autoimmun. 2005 Mar;24(2):153-67.PMID: 15829408 [PubMed - indexed for MEDLINE]Related articles

    9.

    IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.

    Bonifacio E, Lampasona V, Bingley PJ.

    J Immunol. 1998 Sep 1;161(5):2648-54.PMID: 9725268 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.

    Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG.

    Diabetes. 1997 Nov;46(11):1907-10.PMID: 9356046 [PubMed - indexed for MEDLINE]Related articles

    11.

    Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.

    Sabbah E, Savola K, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Akerblom HK, Knip M.

    J Clin Endocrinol Metab. 1999 May;84(5):1534-9.PMID: 10323375 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.

    Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Akerblom HK, Knip M.

    Diabetologia. 1998 Apr;41(4):424-9.PMID: 9562346 [PubMed - indexed for MEDLINE]Related articles

    13.

    Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.

    Morgenthaler NG, Seissler J, Achenbach P, Glawe D, Payton M, Meinck HM, Christie MR, Scherbaum WA.

    Autoimmunity. 1997;25(4):203-11.PMID: 9344328 [PubMed - indexed for MEDLINE]Related articles

    14.

    Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk.

    Hämäläinen AM, Ronkainen MS, Akerblom HK, Knip M.

    J Clin Endocrinol Metab. 2000 Nov;85(11):4249-53.PMID: 11095462 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.

    Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RD.

    Diabetes. 1997 Aug;46(8):1270-5.PMID: 9231650 [PubMed - indexed for MEDLINE]Related articles

    16.

    [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives]

    Kretowski A, Kowalska I, Peczyńska J, Urban M, Kinalska I.

    Przegl Lek. 2000;57(3):143-6. Polish. PMID: 10909282 [PubMed - indexed for MEDLINE]Related articles

    17.

    Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.

    Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Riccardi G, Travaglini P, Morenghi E, Bosi E, Pozzilli P.

    Eur J Endocrinol. 2006 Mar;154(3):441-7.PMID: 16498058 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.

    Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M.

    Diabetologia. 1998 Nov;41(11):1293-7.PMID: 9833935 [PubMed - indexed for MEDLINE]Related articles

    19.

    Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes.

    Kawasaki E, Kuriya G, Satoh T, Fujishima K, Moriuchi A, Fukushima K, Ozaki M, Abiru N, Yamasaki H, Eguchi K.

    Ann N Y Acad Sci. 2008 Dec;1150:248-51.PMID: 19120305 [PubMed - indexed for MEDLINE]Related articles

    20.

    Islet cell antibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after-kidney transplantation.

    Jaeger C, Hering BJ, Dyrberg T, Federlin K, Bretzel RG.

    Transplantation. 1996 Aug 15;62(3):424-6.PMID: 8779696 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity